While Johnson & Johnson evolves to address the most pressing needs of patients, our purpose remains the same. For more than 80 years, Our Credo has reminded us of our responsibilities to the people we serve: patients, doctors and nurses, employees, communities and investors.
Championing global health equity
healthcare workers reached, bringing our total to ~2.3 million in the last 3 years
doses of VERMOX (mebendazole) delivered, treating up to 100 million children and women of reproductive age for soil-transmitted helminths
operating room and hospital staff trained in resource-limited settings
Empowering our employees
First dedicated Global Learning Day for all employees – amounting to more than 196,000 training hours in 220,000 different J&J Learn sessions on the day and throughout October combined
of employees responded to Our Credo Survey, with 85% reporting management provides an inclusive work environment
employee volunteer hours with our community partners through our signature Talent for Good programs
Advancing environmental health
of Johnson & Johnson’s global electricity needs come from renewable sources, including 100% for our operations in Europe, the U.S. and Canada
reduction of our absolute Scope 1 & 2 GHG emissions since 2021
countries have hospitals partnering with Johnson & Johnson on our recycling program for single-use medical devices
Leading with accountability & innovation
invested in research & development across Innovative Medicine and MedTech
total spend with small and diverse suppliers
Enhanced our Code of Business Conduct and Enterprise Risk Management Framework and related governance, reflecting our commitment to compliance and responsible operations
For full details of our performance and notes on all data points, see our ESG Performance Data and Indices.
Recognitions
ESG ratings
1 The use by Johnson & Johnson of any MSCI ESG Research LLC or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Johnson & Johnson by MSCI. MSCI services and data are the property of MSCI or its information providers, and are provided “as-is” and without warranty. MSCI names and logos are trademarks or service marks of MSCI.
